Dear Colleague,
There are five job openings in Program at NIDA HQ in Rockville, MD. Two are in the Division of Neuroscience and Behavior and three are in the Division of Therapeutics and Medical Consequences. Please scroll down to view all of the vacancies.
Division of Neuroscience and Behavior (DNB)
National Institute on Drug Abuse (NIDA)
National Institutes of Health
The Behavioral Cognitive Neuroscience Branch (BCN), within the Division of Neuroscience and Behavior at NIDA, is seeking applicants for the position of Program Officer. The selected candidate will oversee an extramural research program advancing research on the behavioral and cognitive mechanisms underlying substance use disorders (SUD).
BCN supports human and animal experimental investigations of SUD and their underlying mechanisms. This includes a focus on behavioral, cognitive, and neurobiological mechanisms driving the consequences of substance use and underlying the various phases of SUD – including initiation of substance use, compulsive use, abstinence, relapse, and recovery. BCN also supports research on neurocognitive processes fundamental to SUD (e.g., decision-making, reward/punishment learning).
Competitive candidates are expected to have a background informed by neuroscience, psychology, computational psychiatry, or neuroengineering. Criteria for selection include a publication record, prior research experience, or other evidence of a familiarity with current literature in SUD-related cognition and neurobiology.
Interested candidates are strongly encouraged to contact Vani Pariyadath (vani.pariyadath@nih.gov) or Ph: (301) 443-3209
prior to application via USAJOBS.com.
Link to job ad: GS-12/13/14 Health Scientist Administrator (Program Officer/Scientific Review Officer)
Open & closing dates: 01/21/2020 to 01/30/2020
----
The Integrative Neuroscience Branch [IN] within the Division of Neuroscience and Behavior at NIDA is seeking applicants for the position of Program Officer. The selected candidate will oversee an extramural research grant program advancing research on the fundamental neurobiological mechanisms underlying substance use disorders (SUD).
INB supports basic and preclinical research to identify the molecular, cellular and neural circuit adaptations underlying drug addiction. This includes studies of signal transduction, neuronal excitability, neuron-glia interactions, and neuroimmune responses in the regulation of neurotransmission and neural circuit activity in substance use disorders, pain and co-occurring disorders such as HIV/AIDS.
Competitive candidates are expected to have training and research experience in areas of neuroscience research relevant to understanding the neurobiology of SUD. Criteria for selection include a strong publication record, prior research experience, or other evidence of a familiarity with current literature in SUD-related neurobiology and behavior. Interested candidates are strongly encouraged to contact Dr. Roger Sorensen (roger.sorensen@nih.gov, 301-443-3205) prior to application via USAJOBS.com.
Division of Therapeutics and Medical Consequences (DTMC)
National Institute on Drug Abuse (NIDA)
National Institutes of Health
The Division of Therapeutics and Medical Consequences (DTMC) supports and conducts studies to evaluate the safety and efficacy of new pharmacotherapies, behavioral therapies, devices, and digital therapeutics to treat Substance Use Disorders (SUDs). DTMC supports research and development, through peer-reviewed grants and contracts, for all stages of the medication development process including synthesis and preclinical evaluation of potential therapeutics, clinical trial design and execution, and preparing regulatory submissions.
Clinical Grants Research: The incumbent is responsible for providing technical leadership and guidance for the development of new interventions, including helping lead the therapeutics development research program that ranges from preclinical models through to clinical testing in Phase I, Phase II and Phase III trials. The preferred candidate will have experience with clinical studies involving SUD treatment as well as experience in behavioral therapies as many SUD treatments involve behavioral interventions. Primary areas of focus include: evaluation of therapeutics to prevent the initiation and progression of SUDs, critically assessing the field to identify gaps in research, promoting high-quality research, and identifying new areas of therapeutic research that advance NIDA’s mission. The position includes leading a portfolio of grants and contracts, identifying major areas of program development, evaluating research results, and representing NIDA and the NIH at scientific meetings and regulatory agencies to assure the advancement of treatments for SUDs. Contact Dr. Kevin Walton, (kevin.walton@nih.gov) 301-827-5980.
Medication Discovery and Toxicology: The incumbent is responsible for helping lead a therapeutics development research program that ranges from preclinical models through to clinical testing in Phase I, Phase II and Phase III trials. The selected candidate will function as a member of the Addiction Treatment Discovery Program and will be directly involved in the preclinical evaluation of novel compounds as potential treatments for substance use disorders. Preclinical experience in vivo behavioral pharmacology, toxicology, and in vitro receptor binding or related neuroscience is desirable. The position includes managing a portfolio of grants and contracts, including the close monitoring of contract activity and progress through the design of protocols and review of study reports. The ability to function as part of a highly productive team is essential, in addition to representing NIDA and the NIH at scientific meetings. Contact Dr. Jane B. Acri, (jacri@nih.gov) 301-827-5907.
Chemistry and Pharmaceutics: The incumbent is responsible for managing a research program of grants and contracts evaluating chemical design, synthesis, metabolism, pharmacokinetic and pharmacodynamic, and biopharmaceutics related to the discovery and development of new medications for drug abuse treatment research. The incumbent is also responsible for key aspects of the research and production of new novel chemical compounds with potential for drug abuse treatment. He or she will establish and maintain liaison with prominent members of the scientific community to continually evaluate the adequacy of pharmaceutical research in the area of SUD and initiate efforts to direct research to underrepresented areas in the field. Contact: Dr. Rik Kline (rkline@nih.gov) 301-827-5243.
For all positions, the candidate will have a Ph. D in a relevant discipline, and salary will be commensurate with experience. A full Civil Service package of benefits (including retirement, health, life, and long-term care insurance, as well as Thrift Savings Plan, etc.) is available. DHHS, NIH, and NIDA ARE EQUAL OPPORTUNITY EMPLOYERS. Applications from women, minorities, and persons with disabilities are strongly encouraged to apply.
----
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
